Stay updated on Pediatric Galcanezumab for Episodic Migraine Clinical Trial
Sign up to get notified when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.

Latest updates to the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page
- Check4 days agoChange DetectedFooter now shows Revision: v3.3.3; the HHS Vulnerability Disclosure link and the Revision: v3.3.2 reference were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page history shows a new revision entry, v3.3.2, replacing the previous v3.3.1.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0 from the site revision banner; this is a minor update that does not affect study records or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe government funding status banner was removed from the page. It previously informed users about operating status updates and potential delays.SummaryDifference0.2%

- Check47 days agoChange DetectedNew history entries dated 2025-11-05 show updates to Contacts/Locations and Study Status. The 2025-11-04 entry (101) is listed, and the 2025-10-16 entry was removed.SummaryDifference0.2%

- Check54 days agoChange DetectedNew version entries were added to the Record History, reflecting recent updates to the trial's status and contacts/locations.SummaryDifference0.0%

Stay in the know with updates to Pediatric Galcanezumab for Episodic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.